Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Non Operating Income (2011 - 2026)

Analysis

Cerenome (CNSY) Non Operating Income (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn -
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn -
5 Revolution Medicines 44.41 Bn 44.41 Bn - -139.24 Mn
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -51.63 Mn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -
10 Cerenome 20.42 Mn 11.83 Mn - 51,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51,000.00
Mar 31, 2026 173,000.00
Dec 31, 2025 29,000.00
Sep 30, 2025 59,000.00
Jun 30, 2025 6.69 Mn
Mar 31, 2025 -13.87 Mn
Dec 31, 2024 -3,000.00
Sep 30, 2024 925,000.00
Jun 30, 2024 757,000.00
Mar 31, 2024 38,000.00
Dec 31, 2023 48,000.00
Sep 30, 2023 32,000.00
Jun 30, 2023 8,000.00
Mar 31, 2023 -83,000.00
Dec 31, 2022 -86,000.00
Sep 30, 2022 -125,000.00
Jun 30, 2022 -162,000.00
Mar 31, 2022 -190,000.00
Dec 31, 2021 -216,000.00
Sep 30, 2021 -225,000.00